MedTrace Logo

Comprehensive Assessment of Risks for Miscarriage.

NCT04456660 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-10-26

No results posted yet for this study

Summary

This study aims to determine the role of serum biomarkers and placental bloodflow in the comprehensive evaluation of the risk for spontaneous abortion

Conditions

  • Spontaneous Abortion

Interventions

DIAGNOSTIC_TEST

Markers of ultrasound

CRL, HR, and other ultrasound measurements.

DIAGNOSTIC_TEST

Immunologic factors

Measurement of NK cells subpopulations types in the maternal serum

DIAGNOSTIC_TEST

Serum factors

Measuring the maternal serum concentration of sFlt-1, PLGF, glycodelin-A, and other substances.

Sponsors & Collaborators

  • Orthogyn Medical Center, Bulgaria

    lead OTHER

Principal Investigators

  • Petar N Ignatov, PhD · Orthogyn Medical Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-20
Primary Completion
2023-11-20
Completion
2023-12-01

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456660 on ClinicalTrials.gov